Mechanistic study of cycloastragenol in improving heart failure by regulating PI3K/AKT/mTOR signaling and ferroptosis.
Heart failure (HF) is the end stage of various cardiovascular diseases, and persistent myocardial injury and adverse remodeling are major causes of its high hospitalization and mortality rates worldwide. Therefore, it is important to identify key molecules and effective agents that can slow or reverse HF progression. C...